Preparation and in vitro evaluation of a new fentanyl patch based on functional and non-functional pressure sensitive adhesives

AAPS PharmSciTech

Volumn 11, Issue 1, 2010, Pages 278-284

  Taghizadeh, Seyed Mojtaba ^a   Soroushnia, Arezou ^a   Mohamadnia, Fatemeh ^a  

^a IRAN POLYMER AND PETROCHEMICAL INSTITUTE   (Iran)

Author keywords

Adhesion properties; Fentanyl; Peel strength; Pressure sensitive adhesive; Skin permeation; Tack; Transdermal drug delivery system

Indexed keywords

FENTANYL;

ADHESION; ANIMAL EXPERIMENT; ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; HYDRODYNAMICS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN PENETRATION; TRANSDERMAL PATCH;

ADHESIVES; ADMINISTRATION, CUTANEOUS; ANIMALS; DOSAGE FORMS; EXCIPIENTS; FENTANYL; MALE; PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; SKIN;

EID: 77950916053     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9366-3     Document Type: Article

References (21)

1. A Mehdizadeh MH Ghahremani MR Rouini T Toliyat 2006 Effects of pressure sensitive adhesives and chemical permeation enhancers on permeability of fentanyl through excised rat skin Acta Pharm. 56 219 229 1:CAS:528: DC%2BD28XltValsL0%3D 16613727
2. A Boucand L Machet B Arbeille MC Machet M Sourance A Mavon F Patat L Vaillant 2001 Ultrasound-enhanced transderam transport of fentanyl and caffeine across human and hairless rat skin Int J Pharm. 228 69 77 10.1016/S0378-5173(01) 00820-1 (Pubitemid 32905366)
3. S Collaud T Warloe O Jordan R Gurny N Lange 2007 Clinical evaluation of bioadhesive hydrogels for topical delivery of hexylaminolevulinate to Barrett's esophagus J Control Release. 2 3 203 210 10.1016/j.jconrel.2007.08.015 (Pubitemid 350007823)
4. DL Cichewicz SP Welch FL Smith 2005 Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal delta9-tetrahydrocannabinol Eur J Pharmacol. 525 1-3 74 82 10.1016/j.ejphar.2005.09.039 1:CAS:528: DC%2BD2MXht1Gnt7fO 16288738 (Pubitemid 41689024)
5. C Goicoechea E Sánchez C Cano N Jagerovic MI Martín 2008 Algesic activity and pharmacological characterization of N-[1-phenylpyrazol-3- yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally Eur J Pharmacol. 595 22 29 10.1016/j.ejphar.2008.07.052 1:CAS:528:DC%2BD1cXhtFCktr3M 18706410
6. F Marinangeli A Ciccozzi L Aloisio A Colangeli A Paladini Ch Bajocco S Coaccioli G Varrassi 2007 Improved cancer pain treatment using combined fentanyl-TTS and tramadol Pain Practice. 7 4 307 312 10.1111/j.1533-2500.2007. 00155.x 17986161 (Pubitemid 350142299)
7. IDL Consuelo F Falson RH Guy Y Jasques 2007 Application of microemulsions in dermal and transdermal drug delivery J Control Rel. 122 135 140 10.1016/j.jconrel.2007.05.017 (Pubitemid 47361402)
8. A Mehdizadeh T Toliate MR Rouni SH Abaszadeh F Dorkoosh 2004 Design and in vitro evaluation of new drug-in-adhesive formulations of fentanyl transdermal patches Acta Pharm. 54 301 317 1:CAS:528:DC%2BD2MXhtVWltrc%3D 15634614 (Pubitemid 40143816)
9. Stefano FJE, Scasso AF, inventors; Stites & Haribson PLLC, assignee. Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised. United States Patent US 20050208116 A1. 2005 Sep 22.
10. R Panchagnula 1997 Transdermal delivery of drugs Ind J Pharmacol. 29 140 156 1:CAS:528:DyaK2sXkslCqurg%3D (Pubitemid 27296932)
11. Stefano FJE, Scasso AF, inventors; Thalas Group Incorporated, assignee. Transdermal delivery device for the administration of fentanyl. WO Patent WO 03/097008 A2. 2003 Nov 27.
12. SM Taghizadeh A Soroushnia H Mirzadeh M Barikani 2009 Preparation and in vitro evaluation of a new fentanyl patch based on acrylic/silicone pressure-sensitive adhesive blends Drug Dev Ind Pharm. 35 487 498 10.1080/03639040802448638 1:CAS:528:DC%2BD1MXkvVyiurs%3D 19043820
13. Urquhart J,Chandrasekaran SK, Shaw JE, inventors, Alza Corporation, assignee. Bandage for transdermally administering scopolamine to prevent nausea. United States Patent US 4,031,894. 1976 June 28.
14. Urquhart J, Chandrasekaran SK, Shaw JE, inventors, Alza Corporation, assigne. Method and therapeutic system for providing chemotherapy transdermally. United States Patent US 4,060,084. 1977 Nov. 29.
15. Urquhart J, Chandrasekaran SK, Shaw JE, inventors, Alza Corporation, assignee. Method and therapeutic system for administering scopolamine transdermally. United States Patent US 4,262,003.1981 Apr.14.
16. C Valenta BG Auner I Loibl 2005 Skin permeation and stability studies of 5-aminolevulinic acid in a new gel and patch preparation J Control Release. 107 3 495 501 10.1016/j.jconrel.2005.07.006 1:CAS:528:DC%2BD2MXhtVCltLrI 16087267 (Pubitemid 41398070)
17. Q Fana KK Sirkar Y Wangb B Michniakc 2004 In vitro delivery of doxycycline hydrochloride based on a porous membrane-based aqueous-organic partitioning system J Control Release. 98 355 365 10.1016/j.jconrel.2004.05.005 (Pubitemid 39093948)
18. SD Roy SY Hou SL Witham GL Flynn 1994 Transdermal delivery of narcotic analgesics: comparative metabolism and permeability of human cadaver skin and hairless mouse skin J Pharm Sci. 83 1723 1728 10.1002/jps.2600831215 1:CAS:528:DyaK2cXms1entrg%3D 7891301
19. SD Roy GL Flynn M Gutierrez GW Cleary 1996 Characterizations of pressure-sensitive adhesives for matrix patch design J Pharm Sci. 85 5 491 495 10.1021/js950415w 1:CAS:528:DyaK28XitFCqtr4%3D 8742940 (Pubitemid 26150982)
20. YN Kaliaa RH Guya 2001 Modeling transdermal drug release Adv Drug Deliv Rev. 48 159 172 10.1016/S0169-409X(01)00113-2 (Pubitemid 32434401)
21. KG Papadokostaki JH Petropoulos 1998 Kinetics of release of a model disperse dye from supersaturated cellulose acetate matrices J Control Release. 54 251 264 10.1016/S0168-3659(97)00158-2 1:CAS:528:DyaK1cXltVCntL8%3D 9766245 (Pubitemid 28412656)